Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05189080 · ClinicalTrials.gov registry record · NA
Twilio Well-Child Visit Pilot Open Trial
A NA study of Child Health and Text Messaging, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT05189080: Completed NA study of Child Health and Text Messaging, sponsored by Wake Forest University Health Sciences.
NCT05189080 is a NA study of Child Health and Text Messaging that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05189080, a NA study of Child Health and Text Messaging, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will use Twilio as a platform for a text messaging campaign to implement timely follow up with parents/guardians of children ages 0 to 17 years who have no-showed for WCVs. The first phase of the study will be an open trial to assess feasibility and acceptability of three different reminder messages, analyze preliminary data, and collect feedback from participants using interviews to identify the top one or two performing messages. Each reminder message will at minimum direct parents/guardians to reschedule by phone or by the patient portal. These findings will be used to conduct the second phase of the study, a randomized controlled trial.
Primary Outcome
If parent/guardian rescheduled well child visit
Conditions Studied
Interventions
- OTHER Survey
- OTHER Interviews
- OTHER Text message reminders
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2021-12-17 |
| Est. Completion | 2022-04-08 |
| Phase | NA |
What the finished NCT05189080 record still lists
NCT05189080 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 2 conditions, with Child Health appearing as the primary indexed condition, and to 3 interventions - of which Survey is the first listed.
NCT05189080 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05189080 about?
NCT05189080 is a clinical study titled "Twilio Well-Child Visit Pilot Open Trial". This project will use Twilio as a platform for a text messaging campaign to implement timely follow up with parents/guardians of children ages 0 to 17 years who have no-showed for WCVs. The first phase of the study will be an open trial to assess feasibility and acceptability of three different remi...
What is the current status of trial NCT05189080?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2021-12-17. Estimated completion is 2022-04-08.
What conditions does trial NCT05189080 study?
This clinical trial studies the following conditions: Child Health, Text Messaging.
What interventions are being tested in trial NCT05189080?
The interventions under investigation include: Survey (OTHER), Interviews (OTHER), Text message reminders (OTHER).
Who is sponsoring clinical trial NCT05189080?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05189080 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Child Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05189080's enrollment target sits among peer trials
500 193rd of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI